TY  - JOUR
AU  - Carmona-Bayonas, Alberto
AU  - Verso, Melina
AU  - Sánchez Cánovas, Manuel
AU  - Rubio Pérez, Jaime
AU  - García de Herreros, Marta
AU  - Martínez Del Prado, Purificación
AU  - Fernández Pérez, Isaura
AU  - Quintanar Verduguez, Teresa
AU  - Obispo Portero, Berta
AU  - Pachón Olmos, Vanessa
AU  - Gómez, David
AU  - Ortega, Laura
AU  - Serrano Moyano, Marta
AU  - M Brozos, Elena
AU  - Biosca, Mercedes
AU  - Antonio Rebollo, Maite
AU  - Teijeira Sanchez, Lucía
AU  - Hernández Pérez, Carolina
AU  - David Cumplido Burón, José
AU  - Martínez Lago, Nieves
AU  - García Pérez, Estefanía
AU  - Muñoz Langa, Jose
AU  - Pérez Segura, Pedro
AU  - Martínez de Castro, Eva
AU  - Jimenez-Fonseca, Paula
AU  - Agnelli, Giancarlo
AU  - Muñoz, Andrés
PY  - 2022
DO  - 10.1055/a-1816-8347
UR  - http://hdl.handle.net/10668/19658
T2  - Thrombosis and haemostasis
AB  -  Venous thromboembolism (VTE) is a common complication in cancer patients. Much of its morbidity stems from the development of fatal pulmonary embolisms (PE). Little is known about the factors involved in clot stability, with angiogenesis possibly...
LA  - en
KW  - Anticoagulants
KW  - Bevacizumab
KW  - Humans
KW  - Neoplasms
KW  - Pulmonary Embolism
KW  - Registries
KW  - Risk Factors
KW  - Thrombosis
KW  - Venous Thromboembolism
TI  - Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.
TY  - research article
VL  - 122
ER  -